C4 Therapeutics Inc (NAS:CCCC)
$ 4.3 -0.25 (-5.49%) Market Cap: 303.53 Mil Enterprise Value: 132.63 Mil PE Ratio: 0 PB Ratio: 1.25 GF Score: 62/100